Kynurenine metabolism is altered in mdx mice: a potential muscle to brain connection
- PMID: 35912981
- DOI: 10.1113/EP090381
Kynurenine metabolism is altered in mdx mice: a potential muscle to brain connection
Abstract
New findings: What is the central question in this study? Promoting muscle health with regular aerobic exercise can improve mental health through a kynurenine metabolic pathway: do conditions of muscle disease such as muscular dystrophy negatively influence this pathway? What is the main finding and its importance? The DBA/2J mdx model of Duchenne muscular dystrophy exhibits altered kynurenine metabolism with less kynurenic acid and peroxisome proliferator-activated receptor-γ coactivator 1-α and higher levels of tumour necrosis factor α mRNA - results associated with anxiety-like behaviour.
Abstract: Regular exercise can direct muscle kynurenine (KYN) metabolism toward the neuroprotective branch of the kynurenine pathway thereby limiting the accumulation of neurotoxic metabolites in the brain and contributing to mental resilience. However, the effect of muscle disease on KYN metabolism has not yet been investigated. Previous work has highlighted anxiety-like behaviours in approximately 25% of patients with Duchenne muscular dystrophy (DMD), possibly due to altered KYN metabolism. Here, we characterized KYN metabolism in mdx mouse models of DMD. Young (8-10 week old) DBA/2J (D2) mdx mice, but not age-matched C57BL/10 (C57) mdx mice, had lower levels of circulating kynurenic acid (KYNA) and lower KYNA:KYN ratio compared with their respective wild-type (WT) controls. While both C57 and D2 mdx mice displayed signs of anxiety-like behaviour, spending more time in the corners of the arena during a novel object recognition test, this effect was more prominent in D2 mdx mice. Correlational analysis detected a significant negative association between KYNA:KYN levels and time spent in corners in D2 mice, but not C57 mice. In extensor digitorum longus muscles from D2 mdx mice, but not C57 mdx mice, we found lowered protein levels of peroxisome proliferator-activated receptor-γ coactivator 1-α and kynurenine amino transferase-1 enzyme when compared with WT. Furthermore, D2 mdx quadriceps muscles had the highest level of tumour necrosis factor α expression, which is suggestive of enhanced inflammation. Thus, our pilot work shows that KYN metabolism is altered in D2 mdx mice, with a potential contribution from altered muscle health.
Keywords: KYNA; anxiety; mental health; muscular dystrophy.
© 2022 The Authors. Experimental Physiology © 2022 The Physiological Society.
Similar articles
-
Retention of stress susceptibility in the mdx mouse model of Duchenne muscular dystrophy after PGC-1α overexpression or ablation of IDO1 or CD38.Hum Mol Genet. 2024 Mar 20;33(7):594-611. doi: 10.1093/hmg/ddad206. Hum Mol Genet. 2024. PMID: 38181046 Free PMC article.
-
Characterization of Alzheimer's disease-like neuropathology in Duchenne's muscular dystrophy using the DBA/2J mdx mouse model.FEBS Open Bio. 2022 Jan;12(1):154-162. doi: 10.1002/2211-5463.13317. Epub 2021 Nov 11. FEBS Open Bio. 2022. PMID: 34668666 Free PMC article.
-
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.mdx mouse model of Duchenne muscular dystrophy.Am J Physiol Cell Physiol. 2024 Apr 1;326(4):C1011-C1026. doi: 10.1152/ajpcell.00638.2023. Epub 2023 Dec 25. Am J Physiol Cell Physiol. 2024. PMID: 38145301
-
Humanization of the mdx Mouse Phenotype for Duchenne Muscular Dystrophy Modeling: A Metabolic Perspective.J Neuromuscul Dis. 2023;10(6):1003-1012. doi: 10.3233/JND-230126. J Neuromuscul Dis. 2023. PMID: 37574742 Free PMC article. Review.
-
Kynurenine pathway in depression: A systematic review and meta-analysis.Neurosci Biobehav Rev. 2018 Jul;90:16-25. doi: 10.1016/j.neubiorev.2018.03.023. Epub 2018 Mar 30. Neurosci Biobehav Rev. 2018. PMID: 29608993
Cited by
-
Spatiotemporal diversity in molecular and functional abnormalities in the mdx dystrophic brain.Mol Med. 2025 Mar 20;31(1):108. doi: 10.1186/s10020-025-01109-5. Mol Med. 2025. PMID: 40114059 Free PMC article.
-
Retention of stress susceptibility in the mdx mouse model of Duchenne muscular dystrophy after PGC-1α overexpression or ablation of IDO1 or CD38.Hum Mol Genet. 2024 Mar 20;33(7):594-611. doi: 10.1093/hmg/ddad206. Hum Mol Genet. 2024. PMID: 38181046 Free PMC article.
-
Exploratory Analysis of Gut Microbiota Profile in Duchenne Muscular Dystrophy (DMD) Patients with Intellectual Disability.Mol Neurobiol. 2025 Sep;62(9):11799-11809. doi: 10.1007/s12035-025-04974-7. Epub 2025 May 5. Mol Neurobiol. 2025. PMID: 40325330 Free PMC article.
References
REFERENCES
-
- Agudelo, L. Z., Femenia, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J. C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., Pettersson, A. T., Ferreira, D. M. S., Krook, A., Barres, R., Zierath, J. R., Erhardt, S., Lindskog, M., & Ruas, J. L. (2014). Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell, 159(1), 33-45.
-
- Agudelo, L. Z., Ferreira, D. M. S., Dadvar, S., Cervenka, I., Ketscher, L., Izadi, M., Zhengye, L., Furrer, R., Handschin, C., Venckunas, T., Brazaitis, M., Kamandulis, S., Lanner, J. T., & Ruas, J. L. (2019). Skeletal muscle PGC-1α1 reroutes kynurenine metabolism to increase energy efficiency and fatigue-resistance. Nature Communications, 10(1), 2767-2767.
-
- Allison, D. J., & Ditor, D. S. (2014). The common inflammatory etiology of depression and cognitive impairment: A therapeutic target. Journal of Neuroinflammation, 11(1), 151.
-
- Allison, D. J., & Ditor, D. S. (2015). Targeting inflammation to influence mood following spinal cord injury: A randomized clinical trial. Journal of Neuroinflammation, 12(1), 204.
-
- Allison, D. J., & Ditor, D. S. (2018). Maintenance of diet participation in individuals with spinal cord injury: Effect on mood and neuropathic pain. Spinal Cord Series and Cases, 4(1), 97.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources